Overview
Community Health Systems, Inc., headquartered in the United States, operates as a prominent player in the healthcare industry, primarily focusing on providing hospital care services. Through its network of affiliated hospitals, the company delivers a broad range of inpatient and outpatient services, catering to a diverse patient demographic across non-urban and mid-sized markets. It manages, owns, or leases over 80 hospitals in 16 states and continually invests in hospital facilities and healthcare technology to enhance service quality and operational efficacy. Key projects often include hospital modernization, expansion of services such as emergency room operations, and implementation of advanced information systems to streamline healthcare management and improve patient care outcomes. Community Health Systems is dedicated to improving health access in the regions it serves while efficiently managing community-based hospitals.
Basic Stats
The share price of Community Health Systems, Inc. as of September 5, 2025 is $2.92 / share. This is an increase of 5.62% from the prior week. The market cap (or net worth) of Community Health Systems, Inc. as of September 5, 2025 is $389.99 MM.
The Factor Analysis chart (below right) shows a view of Community Health Systems, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 389.99 MM |
| EV | 11,329.99 MM |
| Shares Out. | 133.79 MM |
| Earnings Date | |
| EPS (TTM) | -1.44 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.55 |
| Short Shares Avail. | 1.10 MM |
| Short Interest | 13.88 MM |
| Short Float | 13.42 % |
| Days to Cover | 8.19 days |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | -47.38 % |
| Volatility (1 yr) | 0.67 |
| Beta | 1.77 |
| Sharpe Ratio (1 yr) | -0.77 |
| Sortino Ratio (1 yr) | -1.12 |
| PE Ratio | -2.03 |
| Price/Book | -0.36 |
| Price/TBV | -0.07 |
| Book/Market | -2.82 |
| EBIT/EV | 0.01 |
| EBIT(3yr avg)/EV | 0.02 |
| ROA | -0.01 |
| ROE | |
| ROIC | -0.02 |
| CROIC | 0.04 |
| OCROIC | 0.05 |
| Implied Volatility | 63.79 % |
| Put/Call OI Ratio | 2.40 |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Community Health Systems, Inc. is $3.50. The forecasts range from a low of $2.52 to a high of $5.25. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Community Health Systems, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-01-19 | Oppenheimer | Outperform | Maintains | |
| 2022-11-23 | Credit Suisse | Neutral | Maintains | |
| 2022-08-01 | Credit Suisse | Neutral | Maintains | |
| 2022-07-29 | Oppenheimer | Outperform | Maintains | |
| 2022-06-17 | Loop Capital | Hold | Initiate | |
| 2022-06-15 | B of A Securities | Buy | Neutral | Downgrade |
| 2022-05-02 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-04-29 | RBC Capital | Outperform | Maintains | |
| 2022-04-29 | Citigroup | Buy | Maintains | |
| 2022-03-29 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-12-13 | B of A Securities | Underperform | Buy | Upgrade |
| 2021-10-29 | Credit Suisse | Neutral | Maintains | |
| 2021-09-24 | UBS | Neutral | Initiate | |
| 2021-08-03 | Barclays | Underweight | Maintains | |
| 2021-07-30 | Credit Suisse | Neutral | Maintains | |
| 2021-07-09 | Seaport Global | Neutral | Initiate | |
| 2021-06-10 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2021-05-05 | Jefferies | Hold | Buy | Upgrade |
| 2021-04-30 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2021-02-19 | Credit Suisse | Underperform | Maintains | |
| 2020-05-04 | Oppenheimer | Outperform | Maintains | |
| 2020-02-20 | Raymond James | Underperform | Market Perform | Upgrade |
| 2020-02-20 | B of A Securities | Underperform | Maintains | |
| 2019-12-18 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2018-10-31 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2018-08-16 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-08-14 | Barclays | Underweight | Initiate | |
| 2018-07-30 | Baird | Neutral | Neutral | Maintains |
| 2018-07-27 | Bank of America | Underperform | Underperform | Maintains |
| 2018-07-13 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-01-03 | Goldman Sachs | Sell | Initiate | |
| 2017-12-14 | JP Morgan | Neutral | Underweight | Downgrade |
| 2017-11-03 | Morgan Stanley | Underweight | Maintains | |
| 2017-11-03 | Citigroup | Neutral | Maintains | |
| 2017-11-02 | Credit Suisse | Underperform | Initiate | |
| 2017-08-03 | Deutsche Bank | Hold | Maintains | |
| 2017-06-07 | Morgan Stanley | Underweight | Initiate | |
| 2017-04-05 | Deutsche Bank | Hold | Initiate | |
| 2017-03-01 | PiperJaffray | Neutral | Underweight | Downgrade |
| 2017-02-22 | Baird | Underperform | Neutral | Upgrade |
| 2017-02-21 | Mizuho | Underperform | Neutral | Upgrade |
| 2017-01-04 | PiperJaffray | Neutral | Initiate | |
| 2016-11-11 | Credit Suisse | Neutral | Underperform | Downgrade |
| 2016-10-27 | Mizuho | Neutral | Underperform | Downgrade |
| 2016-10-27 | Baird | Neutral | Underperform | Downgrade |
| 2016-10-24 | Wolfe Research | Peer Perform | Initiate | |
| 2016-09-30 | Citigroup | Neutral | Maintains | |
| 2016-09-14 | Susquehanna | Neutral | Positive | Upgrade |
| 2016-08-12 | Mizuho | Underperform | Neutral | Upgrade |
| 2016-08-09 | Leerink Swann | Outperform | Market Perform | Downgrade |
| 2016-08-05 | Citigroup | Neutral | Maintains | |
| 2016-08-04 | Barclays | Equal-Weight | Maintains | |
| 2016-08-03 | UBS | Buy | Neutral | Downgrade |
| 2016-07-29 | Credit Suisse | Neutral | Initiate | |
| 2016-05-24 | Morgan Stanley | Underweight | Downgrade | |
| 2016-05-04 | Leerink Swann | Market Perform | Outperform | Upgrade |
| 2016-05-03 | Bank of America | Neutral | Underperform | Downgrade |
| 2016-04-25 | Raymond James | Market Perform | Underperform | Downgrade |
| 2016-02-17 | Oppenheimer | Outperform | Maintains | |
| 2016-02-17 | Barclays | Equal-Weight | Maintains | |
| 2016-02-16 | SunTrust Robinson Humphrey | Buy | Neutral | Downgrade |
| 2016-02-16 | Mizuho | Neutral | Underperform | Downgrade |
| 2016-02-16 | Jefferies | Buy | Hold | Downgrade |
| 2016-02-16 | Avondale Partners | Market Outperform | Market Perform | Downgrade |
| 2016-01-28 | Raymond James | Underperform | Market Perform | Upgrade |
| 2016-01-08 | Wedbush | Outperform | Neutral | Downgrade |
| 2016-01-06 | Raymond James | Market Perform | Underperform | Downgrade |
| 2016-01-06 | Barclays | Equal-Weight | Maintains | |
| 2016-01-04 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2015-10-27 | Leerink Swann | Outperform | Market Perform | Downgrade |
| 2015-10-26 | Baird | Outperform | Neutral | Downgrade |
| 2015-10-22 | Susquehanna | Positive | Neutral | Downgrade |
| 2015-10-22 | Raymond James | Market Perform | Outperform | Downgrade |
| 2015-10-22 | Mizuho | Buy | Neutral | Downgrade |
| 2015-10-22 | Bank of America | Buy | Neutral | Downgrade |
| 2015-10-08 | Barclays | Equal-Weight | Maintains | |
| 2015-09-16 | JP Morgan | Neutral | Initiate | |
| 2015-08-24 | Mizuho | Buy | Maintains | |
| 2015-08-13 | Raymond James | Market Perform | Outperform | Upgrade |
| 2015-08-05 | Jefferies | Buy | Maintains | |
| 2015-07-16 | KeyBanc | Overweight | Downgrade | |
| 2015-06-29 | Mizuho | Neutral | Buy | Upgrade |
| 2015-06-26 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2015-06-26 | Raymond James | Outperform | Market Perform | Downgrade |
| 2015-06-26 | Oppenheimer | Outperform | Maintains | |
| 2015-06-26 | Mizuho | Neutral | Buy | Upgrade |
| 2015-06-26 | Jefferies | Buy | Maintains | |
| 2015-06-10 | Wedbush | Outperform | Initiate | |
| 2015-01-08 | Credit Suisse | Outperform | Maintains | |
| 2014-12-18 | Sterne Agee | Buy | Initiate | |
| 2014-11-12 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2014-11-05 | Barclays | Equal-Weight | Maintains | |
| 2014-11-04 | Credit Suisse | Outperform | Maintains | |
| 2014-10-02 | KeyBanc | Buy | Maintains | |
| 2014-09-09 | Deutsche Bank | Buy | Maintains | |
| 2014-08-05 | Credit Suisse | Outperform | Maintains | |
| 2014-08-05 | Citigroup | Neutral | Maintains | |
| 2014-08-04 | Cantor Fitzgerald | Hold | Maintains | |
| 2014-08-04 | Barclays | Equal-Weight | Maintains | |
| 2014-08-01 | Jefferies | Buy | Maintains | |
| 2014-06-26 | KeyBanc | Buy | Maintains | |
| 2014-06-03 | JP Morgan | Overweight | Maintains | |
| 2014-05-19 | Cantor Fitzgerald | Hold | Maintains | |
| 2014-05-12 | BMO Capital | Market Perform | Maintains | |
| 2014-05-08 | FBR Capital | Outperform | Maintains | |
| 2014-05-08 | Barclays | Equal-Weight | Maintains | |
| 2014-04-14 | Oppenheimer | Market Perform | Outperform | Upgrade |
| 2014-03-31 | Monness Crespi Hardt | Buy | Initiate | |
| 2014-03-10 | JP Morgan | Overweight | Maintains | |
| 2014-01-07 | Deutsche Bank | Buy | Maintains | |
| 2013-10-07 | Deutsche Bank | Buy | Maintains | |
| 2013-09-09 | Citigroup | Buy | Neutral | Downgrade |
| 2013-07-22 | Deutsche Bank | Buy | Maintains | |
| 2013-07-11 | KeyBanc | Buy | Initiate | |
| 2013-06-12 | Deutsche Bank | Hold | Buy | Upgrade |
| 2013-04-29 | UBS | Buy | Maintains | |
| 2013-04-23 | Baird | Neutral | Outperform | Upgrade |
| 2013-04-10 | Deutsche Bank | Buy | Hold | Downgrade |
| 2013-03-27 | BMO Capital | Underperform | Market Perform | Upgrade |
| 2013-03-25 | JP Morgan | Overweight | Maintains | |
| 2013-03-18 | Jefferies | Hold | Buy | Upgrade |
| 2013-02-26 | BMO Capital | Underperform | Maintains | |
| 2013-02-25 | UBS | Buy | Maintains | |
| 2013-02-25 | Morgan Stanley | Overweight | Maintains | |
| 2013-02-11 | BMO Capital | Market Perform | Underperform | Downgrade |
| 2013-01-30 | Deutsche Bank | Buy | Maintains | |
| 2013-01-25 | UBS | Buy | Maintains | |
| 2013-01-17 | Morgan Stanley | Overweight | Initiate | |
| 2013-01-11 | Bank of America | Neutral | Buy | Upgrade |
| 2012-12-18 | JP Morgan | Overweight | Initiate | |
| 2012-11-26 | Baird | Outperform | Neutral | Downgrade |
| 2012-11-12 | Imperial Capital | Outperform | Maintains | |
| 2012-10-11 | Barclays | Equal-Weight | Initiate | |
| 2012-10-08 | Jefferies | Hold | Maintains | |
| 2012-07-26 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-07-02 | Bank of America | Neutral | Maintains | |
| 2012-06-29 | Wells Fargo | Outperform | Upgrade | |
| 2012-05-01 | Goldman Sachs | Neutral | Upgrade | |
| 2012-04-27 | Jefferies | Hold | Maintains | |
| 2012-04-27 | Bank of America | Neutral | Maintains | |
| 2012-03-09 | Cantor Fitzgerald | Hold | Initiate | |
| 2012-03-06 | Jefferies | Hold | Maintains | |
| 2012-02-23 | Deutsche Bank | Buy | Upgrade | |
| 2012-02-23 | Citigroup | Neutral | Maintains | |
| 2012-02-22 | Bank of America | Neutral | Maintains | |
| 2012-02-22 | Auriga | Hold | Maintains | |
| 2023-02-17 | Credit Suisse | Neutral | Maintains | |
| 2023-05-02 | Oppenheimer | Outperform | Reiterate | |
| 2023-05-03 | RBC Capital | Outperform | Maintains | |
| 2023-05-03 | Credit Suisse | Neutral | Maintains | |
| 2023-05-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-05-03 | Citigroup | Buy | Maintains | |
| 2023-10-11 | Truist Securities | Hold | Hold | Maintains |
| 2023-10-30 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-06-20 | Truist Securities | Hold | Hold | Maintains |
| 2023-08-07 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2023-10-20 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-26 | Truist Securities | Hold | Hold | Maintains |
| 2024-02-22 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-04-25 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-03-06 | Barclays | Equal-Weight | Initiate | |
| 2024-07-15 | Truist Securities | Hold | Hold | Maintains |
| 2024-08-14 | UBS | Neutral | Neutral | Maintains |
| 2024-07-30 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-25 | Truist Securities | Hold | Hold | Maintains |
| 2025-04-11 | Truist Securities | Hold | Hold | Maintains |
| 2025-07-16 | Truist Securities | Hold | Hold | Maintains |
| 2024-11-22 | Raymond James | Market Perform | Underperform | Downgrade |
| 2024-07-25 | Oppenheimer | Outperform | Outperform | Maintains |
| 2025-02-20 | UBS | Neutral | Neutral | Maintains |
| 2025-02-20 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-12 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-10-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-06 | Truist Securities | Hold | Hold | Maintains |
| 2024-11-25 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
| 2025-03-10 | Wells Fargo | Underweight | Underweight | Maintains |
| 2025-05-29 | Wells Fargo | Underweight | Underweight | Maintains |
| 2025-07-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-24 | Jefferies | Buy | Hold | Downgrade |
| 2025-04-09 | Guggenheim | Neutral | Initiate | |
| 2025-08-14 | Wells Fargo | Underweight | Underweight | Maintains |
| 2025-07-25 | UBS | Neutral | Neutral | Maintains |
| 2025-07-25 | RBC Capital | Outperform | Outperform | Maintains |
